RecruitingNot ApplicableNCT06944847

Vaping and Smoking Project in People With Schizophrenia

A Laboratory Study of Behavior and Performance Among People Who Vape Nicotine and/or Smoke Cigarettes - Schizophrenia Supplement


Sponsor

State University of New York at Buffalo

Enrollment

64 participants

Start Date

Feb 15, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The proposed research will characterize withdrawal among people with schizophrenia who vape daily compared to people with schizophrenia who smoke combustible cigarettes daily, filling critical gaps in the understanding of electronic nicotine delivery systems (ENDS) dependence and contributing to the development of vaping cessation interventions amongst people with schizophrenia, the leading preventable cause of death in the US.


Eligibility

Min Age: 21 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is examining the effects of daily nicotine vaping compared to daily cigarette smoking in people who have schizophrenia. The goal is to better understand how these two forms of nicotine use affect health, brain function, and symptoms in this population. **You may be eligible if...** - You vape or smoke cigarettes daily or nearly daily for at least 6 months - A nicotine test (cotinine level) shows you are actively using nicotine regularly - Your antipsychotic medication dose has been stable for at least 6 months **You may NOT be eligible if...** - You are planning to quit vaping or smoking within the next month - You regularly use other tobacco products like pipes, hookah, smokeless tobacco, or nicotine pouches - If assigned to the vaping group: you also regularly smoke cigars or other tobacco products - You use nicotine in forms that would make it hard to separate the effects of vaping versus smoking Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALAcute (24-hour) abstinence

Participants will be asked to abstain from all tobacco/nicotine for 24 hours prior to the visit

BEHAVIORALAd libitum smoking/vaping

Participants will be asked to smoke/vape as usual during the 24 hours prior to the visit


Locations(1)

University at Buffalo

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06944847


Related Trials